Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer

Manish R. Patel, Blake A. Jacobson, Yan Ji, Jeremy Drees, Shaogeng Tang, Kerry Xiong, Hengbing Wang, Jennifer E. Prigge, Alexander S. Dash, Andrea K. Kratzke, Emily Mesev, Ryan Etchison, Mark J. Federspiel, Stephen J. Russell, Robert A. Kratzke

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Abstract

Vesicular stomatitis virus (VSV) is a potent oncolytic virus for many tumors. VSV that produces interferon-β (VSV-IFNβ) is now in early clinical testing for solid tumors. Here, the preclinical activity of VSV and VSV-IFNβ against non-small cell lung cancer (NSCLC) is reported. NSCLC cell lines were treated in vitro with VSV expressing green fluorescence protein (VSV-GFP) and VSV-IFNβ. VSV-GFP and VSV-IFNβ were active against NSCLC cells. JAK/STAT inhibition with ruxolitinib re-sensitized resistant H838 cells to VSV-IFNβ mediated oncolysis. Intratumoral injections of VSV-GFP and VSV-IFNβ reduced tumor growth and weight in H2009 nude mouse xenografts (p < 0.01). A similar trend was observed in A549 xenografts. Syngeneic LM2 lung tumors grown in flanks of A/J mice were injected with VSV-IFNβ intratumorally. Treatment of LM2 tumors with VSV-IFNβ resulted in tumor regression, prolonged survival (p < 0.0001), and cure of 30% of mice. Intratumoral injection of VSV-IFNβ resulted in decreased tumor-infiltrating regulatory T cells (Treg) and increased CD8+ T cells. Tumor cell expression of PDL-1 was increased after VSV-IFNβ treatment. VSVIFNβ has potent antitumor effects and promotes systemic antitumor immunity. These data support further clinical investigation of VSV-IFNβ for NSCLC.

Original languageEnglish (US)
Pages (from-to)33165-33177
Number of pages13
JournalOncotarget
Volume6
Issue number32
DOIs
StatePublished - 2015

Keywords

  • Interferon-β
  • NSCLC
  • Oncolytic virus
  • Treg
  • VSV

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this